Hemostats market forecast points to 7.2% annual growth through 2030

The hemostats market is projected to climb from $3.8 billion in 2026 to $5.02 billion by 2030, driven by more surgeries, more trauma cases and wider use of advanced bleeding-control products. North America led the market in 2025, while Asia-Pacific is expected to grow fastest.

Why it matters: - Hemostats are central to surgery and trauma care because they help control bleeding, support patient safety and improve surgical visibility. - Rising surgical volumes and trauma cases are pushing demand for products that can stop blood loss faster and support shorter recovery times.

What happened: - The Business Research Company said the global hemostats market will grow from $3.56 billion in 2025 to $3.8 billion in 2026. - The market is forecast to reach $5.02 billion by 2030, implying a 7.2% compound annual growth rate. - The report was published Aug. 10, 2026, and covers global market trends, regional dynamics and emerging product categories. - Download a free sample of the report. - View the full hemostats market report.

The details: - Market growth in the recent period was driven by more surgical procedures, expanded hospital surgical capacity, biomaterial advances, stronger demand for blood-loss management and wider use of minimally invasive surgery. - Forecast growth is linked to tighter patient-safety standards, demand for faster recovery, more advanced trauma care centers, new bioactive hemostatic materials and greater use of specialized surgical products. - Expected product trends include advanced combination hemostats, ready-to-use agents, rapid bleeding-control solutions, biocompatible and absorbable products, and a stronger focus on surgical efficiency and safety. - Hemostats work by clamping or compressing blood vessels to control hemorrhage during operations. - Hemostats also help hold deeper tissue in place, improving visibility and access in complex procedures. - The report says North America held the largest market share in 2025. - The report expects Asia-Pacific to post the fastest growth over the forecast period. - The report also covers South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa.

Between the lines: - The market’s growth story is less about one technology shift and more about broad pressure from higher procedure volumes, more complex surgery and stronger demand for safer bleeding-control tools. - Product innovation appears to be moving toward convenience and speed, which suggests hospitals and surgeons are prioritizing workflow efficiency alongside clinical outcomes. - The regional outlook points to a mature market in North America and a faster-expanding opportunity in Asia-Pacific as healthcare access and medical investment rise.

What's next: - The hemostats market is expected to keep expanding through 2030 as surgical volumes, trauma treatment needs and adoption of advanced materials increase. - The report says future coverage now includes market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market-hotspots infographics and future-trend analysis. - Broader use of advanced combination products and absorbable materials is likely to shape purchasing and product development decisions.

The bottom line: - Hemostats remain a core surgical category, and the next phase of growth will likely come from faster, safer and easier-to-use bleeding-control products.